description Emil Frei Overview
Emil Frei was an American physician and oncologist who played a foundational role in the development of modern cancer chemotherapy. Collaborating with Emil Freireich and James Holland at the National Cancer Institute in the 1960s, he demonstrated that combinations of multiple cytotoxic drugs could induce long-term remissions in children with acute lymphoblastic leukemia. This approach, known as combination chemotherapy, established a new treatment paradigm that drastically improved survival rates for pediatric leukemia patients. Frei later directed the Dana-Farber Cancer Institute, continuing his clinical research in oncology.
insights Ranking position
Emil Frei ranks #104 of 150 in the Physician ranking, behind Thomas Sydenham, ahead of Emil Kraepelin.
help Emil Frei FAQ
What foundational cancer treatment did Emil Frei help develop?
Emil Frei co-developed combination chemotherapy, a revolutionary approach that uses multiple different cytotoxic drugs simultaneously. His research proved that drug combinations could overcome cancer cell resistance and cure diseases previously thought fatal.
Who were Emil Frei's primary collaborators at the National Cancer Institute?
Frei worked closely with Emil Freireich and James Holland at the National Cancer Institute (NCI) during the 1960s. Together, they tested aggressive drug regimens on children suffering from acute lymphoblastic leukemia.
Which specific cancer was first cured using Frei's combination chemotherapy?
The most dramatic early success of this research was achieving long-term remissions in childhood acute lymphoblastic leukemia (ALL). By the late 1960s, their VAMP regimen (Vincristine, Amethopterin, Mercaptopurine, and Prednisone) proved that widespread cancer could be cured with drugs.
Where did Emil Frei spend the latter part of his medical career?
Emil Frei became the director of the Dana-Farber Cancer Institute in Boston in 1972. He also served as a physician-in-chief at the Children's Hospital Medical Center in Boston.
explore Explore More
Reviews & Comments
Write a Review
Be the first to review
Share your thoughts with the community and help others make better decisions.
